Chemokines CXCL9 and CCL2 in Relation to Cerebral White Matter Disease, Cognitive Decline, and Dementia
Greater CXCL9 levels were associated with greater white matter lesion load, independent of vascular, renal, and genetic factors, suggesting a role in WMD pathogenesis. WMHV mediated CXCL9's association with cognitive decline and dementia risk. This IFN-γ-induced monokine (MIG) warrants further evaluation as a biomarker of white matter and cognitive health as well as a potentially modifiable therapeutic target.
Authors
- Emir Veledar (ORCID: https://orcid.org/0000-0002-3831-5433)
- José Gutierrez (ORCID: https://orcid.org/0000-0002-2175-8078)
- Hannah E. Gardener (ORCID: https://orcid.org/0000-0003-1416-632X)
- Mohammad Nafeli Shahrestani (ORCID: https://orcid.org/0009-0005-1743-8492)
- Christian Agudelo
- Mitchell S. V. Elkind
- Sarah E. Tom
- Tatjana Rundek
Institutions
- American Heart Association (US)
- University of Miami (US)
- City University of New York (US)
- National Institute of Neurological Disorders and Stroke (US)
- Columbia University (US)
Publication Details
- Journal
- Neurology Open Access
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1212/wn9.0000000000000065
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00